Table 1.

Baseline characteristics of the patients.

Treated with anti-TNF, n = 34
  Women/men21/13
  Age, yrs, mean ± SD48.6 ± 10.3
  RA patients, women/men19 (17/2)
  Mean disease duration, yrs (range)14.5 (7–25)
  Spondyloarthritis patients, women/men15 (4/11)
  Mean disease duration, yrs (range)15 (8–28)
Treated with rituximab, n = 8
  Women/men7/1
  Age, yrs, mean ± SD53 ± 9.7
  Mean disease duration, yrs (range)13.1 (4–27)
Treated with methotrexate, n = 13
  Women/men12/1
  Age, yrs, mean ± SD46 ± 10.6
  Mean disease duration, yrs (range)14.6 (8–25)

  • TNF: tumor necrosis factor; RA: rheumatoid arthritis.